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Abstract
X-linked ichthyosis (XLI) is a rare X-linked dermatological condition arising from deficiency
for the enzyme steroid sulfatase (STS). STS is normally expressed in the brain, and males
with XLI exhibit personality differences from males in the general population, and are at
increased risk of developmental and mood disorders. As the STS gene escapes X-inactiva-
tion, female carriers of XLI-associated genetic mutations have reduced STS expression/
activity relative to non-carrier females, and could manifest similar behavioural phenotypes to
males with XLI. Additionally, as STS activity normally increases in female tissues towards
late pregnancy and into the puerperium, carrier females could theoretically present with
increased rates of postpartum psychopathology. Using a worldwide online survey comprising
custom-designed demographic questionnaires and multiple validated psychological ques-
tionnaires, we collected detailed self-reported information on non-postpartum and postpar-
tum behaviour in confirmed adult (>16yrs) female carriers of genetic mutations associated
with XLI (n = 94) for statistical comparison to demographically-matched previously-published
normative data from female controls (seven independent studies, 98�n�2562), adult males
with XLI (n = 58), and to newly-obtained online survey data from a general population sample
of mothers from the United Kingdom and United States of America (n = 263). The pattern of
results in carrier females relative to controls was remarkably similar to that previously
observed in males with XLI, with evidence for increased rates of developmental and mood
disorders, and elevated levels of inattention, impulsivity, autism-related traits and general
psychological distress. Carrier females exhibited a significantly elevated rate of postpartum
mental health conditions (notably mild depression) relative to controls which could not be
accounted for by social factors. Our data confirm the psychological profile associated with
XLI-associated mutations, and suggest that female carriers may be at increased risk of psy-
chopathology, including in the postpartum period. These findings are relevant to families
affected by XLI, to clinicians involved in the care of these families, and to genetic counsellors.
PLOS ONE | https://doi.org/10.1371/journal.pone.0212330 February 15, 2019 1 / 19
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Cavenagh A, Chatterjee S, Davies W
(2019) Behavioural and psychiatric phenotypes in
female carriers of genetic mutations associated
with X-linked ichthyosis. PLoS ONE 14(2):
e0212330. https://doi.org/10.1371/journal.
pone.0212330
Editor: Sarah E. Medland, QIMR Berghofer Medical
Research Institute, AUSTRALIA
Received: July 23, 2018
Accepted: January 31, 2019
Published: February 15, 2019
Copyright: © 2019 Cavenagh et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: The work was supported by Medical
Research Council (MRC) United Kingdom Centre
Grant MR/L010305/1 (https://mrc.ukri.org/) and
Cardiff University. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Introduction
X-linked ichthyosis (XLI) is a dermatological condition characterised by large, dark brown
scales occurring primarily on the extensor surfaces and trunk [1]. Most cases of XLI are caused
by an X-linked genetic mutation resulting in deficiency for the enzyme steroid sulfatase (STS),
which cleaves sulfate groups from a range of steroids; the skin phenotype results from accumu-
lation of cholesterol sulfate in the stratum corneum [1]. 80–90% of XLI cases are caused by
complete or partial deletion of the STS gene, with the remaining cases being attributed to point
mutations within the gene. The typical deletion encompasses STS and a small number of adja-
cent genes (including members of the VCX family, PUDP, and PLPNA4) whilst larger deletions
can encompass the KAL and NLGN4X genes [2]. Diagnosis of the condition is typically made
on the basis of skin appearance and family history, with additional confirmatory biochemical
and/or genetic analyses performed for some individuals [1]. As it arises from an X-linked
mutation, XLI almost exclusively affects males: in >85% of cases of XLI, the mutation is
thought to be inherited from a heterozygous carrier mother [3,4]. Prevalence rates for XLI
based upon clinical samples range from 1 in 3000 to 1 in 6000 males [1], and for STS deficiency
based upon prenatal screening are approximately 1 in 1500 males [5,6]. These findings suggest
that, in many cases, STS deficiency does not result in clinically-identifiable disease. The inheri-
tance data and prevalence rates above indicate that approximately 1 in 1200 females within the
general population may be heterozygous carrier females, equivalent to ~30,000 individuals in
the United Kingdom, and ~3.1million individuals worldwide.
STS is expressed in the developing [7] and adult [8] human brain, and males with XLI
exhibit a personality and mental health profile distinct from that of males within the general
population [2,4,9,10]; specifically, the former group exhibit higher rates of inattention, impul-
sivity (but not motor impulsivity), mood problems, disruptive behaviour and autism-related
traits, and are more likely to be diagnosed with developmental conditions (including Attention
Deficit Hyperactivity Disorder and autism) and mood disorders. Recently, a case report has
identified a psychotic disorder resembling early-onset schizophrenia in a boy with XLI [11].
Importantly, these findings are unlikely to be confounded by ascertainment biases, in that high
rates of psychopathology are seen in boys with XLI ascertained solely on the basis of maternal
endocrine abnormalities during pregnancy [2], and a remarkably similar suite of behaviours to
that reported in males with XLI is also seen Sts-deficient mouse models [12–16].
The STS gene escapes X-inactivation [17], and carrier females heterozygous for XLI-associ-
ated genetic mutations exhibit reduced STS expression, and reduced protein levels/enzyme
activity [3]. Consistent with this, carrier females can show comparable, though milder, pheno-
types to males with XLI [1]. The behaviour and mental health of carrier females has not been
systematically assessed, although one report has described paranoid schizophrenia in two
female cases with deletions encompassing STS [18]. In female mammals, STS expression/activ-
ity increases during late pregnancy and into the puerperium in blood and brain tissue [19],
whilst carrier mothers are at increased risk of experiencing stressful obstetric complications
(specifically delayed or prolonged labour due to STS absence in the fetal placenta) relative to
general population controls [1]. Hence, we have previously hypothesised that deficiency for
the STS enzyme might result in an increased risk of postpartum psychopathology [19], notably
for postpartum psychosis-related phenotypes [20].
Here, we aimed to determine whether behavioural measures and mental health risk (includ-
ing in the postpartum period) differed between female carriers of XLI-associated genetic muta-
tions and females from the general population, and whether the pattern of differences
mirrored those seen in males with XLI. Using established and effective social media-focussed
recruitment methods [9,21], we undertook an online survey of confirmed female carriers of
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XLI-associated mutations using well-validated and detailed self-report behavioural question-
naire measures. Data related to non-postpartum behaviours were compared to previously-
published demographically-matched normative sample, and adult male XLI, data. Data rele-
vant to the postpartum period were compared to normative data obtained from a demographi-
cally-matched, newly-recruited and online-surveyed general population sample of mothers.
Our a priori hypotheses were that, relative to females within the general population, carrier
females (similar to males with XLI) would exhibit evidence for: impaired attention and a gen-
eral increase in impulsivity (but normal, or reduced, motor impulsivity), hyperactivity,
increased levels of depressive and anxiety-related phenotypes, increased behavioural inflexibil-
ity and social impairment, increased rates of psychotic experiences, and a greater likelihood of
having been diagnosed with one or more developmental, mood, or postpartum psychiatric
disorders.
We successfully recruited, and analysed online survey data from, a comparatively-large
cohort of adult female carriers of XLI-associated genetic mutations from around the world,
and identified a number of behavioural differences compared to normative female samples
which were largely consistent with the aforementioned hypotheses.
Methods
Ethics
The studies were approved by Cardiff University School of Psychology Research Ethics
Committee.
Survey structure for female carriers of XLI-associated genetic mutations
An online survey (Survey 1) was generated using Qualtrics software to be completed by con-
firmed adult (>16yrs) female carriers of genetic mutations associated with XLI. After an online
consent form, the first part of the survey comprised demographic information including par-
ticipant age, ethnic origin, country of residence, handedness, smoker status, and highest edu-
cational level attained. The second part of the survey asked about the basis on which carrier
status was confirmed, and, if a genetic test was performed, the nature of the mutation. The
third part of the survey asked about the participant’s sensory acuity (scored on a Likert scale
from 1 = excellent to 5 = very poor for each sense), general personality type based upon the
‘Four Temperaments’ [22], and any previous diagnosis of developmental, psychiatric or neuro-
degenerative illness.
Participants were then asked to complete a series of five psychological questionnaires
selected on the basis of previous data: i) the Adult ADHD Self-Report Scale version 1.1 (ASRS
v1.1), a five-point response 18-item Likert-scale screening questionnaire assessing recent
attentional (nine items) and hyperactive-impulsive (nine items) traits based on diagnostic cri-
teria for ADHD and previously established for use in adults [23]; the presence of�4 symptoms
(indexed by scores of�2 or�3 depending on the question) from Part A is consistent with, but
not diagnostic for, a presentation of ADHD ii) the Barratt Impulsiveness Scale-11 (BIS-11), a
four-point response 30-item Likert-scale questionnaire assessing aspects of impulsivity [24]
for which total scores, second-order factor scores (attentional, motor and planning impulsiv-
ity) and first-order factor scores (attention, cognitive instability, motor performance, persever-
ance, self-control and cognitive complexity) were calculated, iii) the adult Autism Quotient
(AQ), an extensively-validated four-point response 50-item Likert-scale questionnaire assess-
ing behavioural traits associated with autism spectrum disorders [25]; total and sub-scale
scores (social skill, attention-switching, attention to detail, communication and imagination)
were calculated, iv) the Kessler Psychological Distress Scale (K10) [26], a five-point 10-item
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Likert-scale questionnaire assessing recent depression or anxiety-related traits. K10 items were
scored from 1–5 (total score range 10–50) with a score�20 being consistent with significant
psychological distress and v) the Schizotypal Personality Questionnaire, a 74-item ‘Yes/No’
screen designed to assess behavioural traits associated with schizotypal personality disorder in
the general population, with items endorsed ‘Yes’ scoring one point [27]; total and sub-scale
scores (items of reference, excessive social anxiety, odd beliefs or magical thinking, unusual
perceptual experiences, odd or eccentric behaviour, no close friends, odd speech, constricted
affect and suspiciousness) were calculated. Finally, participants completed a demographic
questionnaire on their childbearing history (including any pregnancy-related medical compli-
cations or postpartum psychiatric diagnoses) and the Community Assessment of Psychic
Experiences (CAPE-42) applied to the 6-week period following the birth of any of their chil-
dren; the CAPE-42 is a 42-item four-point response scale designed to assess the mean fre-
quency (1 = never to 4 = nearly always) and associated distress (1 = not distressed to 4 = very
distressed) of positive, depressive and negative experiences related to psychosis within the gen-
eral population [28]. The survey concluded with a short debrief describing the purpose of the
study and its main hypotheses, links to relevant previous literature, and an explanation of
mechanisms by which the study results would be disseminated.
Survey structure for adult mothers from the general population
A second online survey (Survey 2) was generated using Qualtrics software to be completed by
adult mothers from the general populations of United Kingdom or United States of America
to provide normative behavioural data relating to the postpartum period. After completing an
online consent form, participants completed a general demographic questionnaire before
completing a questionnaire on their childbearing history (including any pregnancy-related
medical complications or postpartum psychiatric diagnoses) and the Community Assessment
of Psychic Experiences (CAPE-42) applied to the 6-week period following the birth of any of
their children. The survey concluded with a short debrief similar to that for Survey 1.
Participant recruitment and survey completion
We conservatively estimated, based upon our previous BIS-11, AQ and K10 data in adult
males with XLI [9], that for two-tailed analyses with α = 0.05, a sample size of 85 female carri-
ers would provide ~83% power to reliably detect an effect size half that observed in males. The
URL for Survey 1 was advertised worldwide via ichthyosis support groups and their websites
(in some cases after additional ethical and academic review), and through social media sites
(including relevant Facebook pages, and Twitter). Participants completed the survey anony-
mously, and results were returned to the research team upon completion. Data were collected
between 17th November 2017 and 7th June 2018. The URL for Survey 2 was advertised via the
Qualtrics online participant panel [29] and respondents were reimbursed in accordance with
standard Qualtrics procedures. Participants completed the survey anonymously, and results
were returned to the research team upon completion. Data were collected between 8-9th Janu-
ary 2018.
Data analysis and statistics
Questionnaires were analysed as previously described in the literature. In the rare circum-
stance of participants not answering specific questions (which occurred<2.5% of the time),
mean values for the group were imputed. Normality of data was assessed using Shapiro-Wilk
test. Summary data are reported as percentages, mean values±standard deviation of the mean
(if normally-distributed) or as median values with 95% confidence limits (if non-normally
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distributed); where non-normally distributed data are being directly compared to normally-
distributed data, mean values±standard deviation of the mean are also presented for the for-
mer. Categorical data were analysed using Chi-Squared test with Yates’ correction or Fisher
Exact Test. Testing to compare behavioural measures in the female carrier sample to the ‘aver-
age’ or mean score was done using a One Sample t-test/Wilcoxon Signed Ranks Test. Traits
within the same set of individuals were compared using paired t-test or Related Samples Wil-
coxon Signed Rank test. Data from female carriers of XLI-associated genetic mutations and
previously-published normative control samples from seven independent studies were com-
pared using Welch’s t-test with the degrees of freedom calculated using the Welch-Sat-
terthwaite equation. P-values were calculated from the resultant t-statistic and degrees of
freedom using online GraphPad software [30]. Data from female carriers of XLI-associated
genetic mutations and adult males with XLI/general population mothers from our newly-
recruited online sample were compared using categorical analyses and unpaired two-tailed t-
test/Mann Whitney U-Test depending upon normality of the data. Summary descriptions of
all control and comparison samples are available in S1 Table. P-values <0.05 were regarded as
nominally-significant. Post hoc Principal Component Analysis (PCA) of the female carrier
data for the 47 measures across ASRS, BIS-11, AQ, K10, SPQ and CAPE-42 questionnaires
using SPSS 25 identified 8 distinct components explaining the majority (83%) of the total sam-
ple variance (Component 1 = 44%, Component 2 = 13%, Component 3 = 6% and Components
4–8 <5% each); thus only p-values<0.00625 (0.05/8) should be regarded as surviving conser-
vative multiple testing correction.
Data availability
Raw survey data are available in S2 and S3 Tables.
Results
Recruitment and demographics of female carrier sample
A total of 104 females responded to Survey 1, 10 of whom were subsequently excluded from
further analysis as their presentation was inconsistent with being a carrier for an XLI-associ-
ated mutation. The demographic features of the remaining 94 individuals, who we had high
confidence were genuine carriers based upon their survey responses, are reported in Table 1.
Although we did not genotype individuals within our female carrier sample, some participants
reported their previously-defined genetic mutation; the ratio of carriers with atypical deletions
(~2.5-5Mb) to carriers with typical deletions (~1.5–1.7Mb) or point mutations is consistent
with previous literature [2,4].
Sensory function in female carriers
Large deletions encompassing STS have been associated with anosmia in some cases [1], whilst
STS is expressed in regions of the developing human tongue [7]; hence, we wanted to assess
basic sensation in our female carrier cohort. Sensory function across all five domains was
reported as being significantly better than average i.e. ‘3’ (p<0.001). Low numbers of individu-
als reported ‘very poor’ sensory function (vision: 2/94, hearing: 1/94, taste: 0/94, smell: 0/94
and touch: 0/94).
Personality types in female carriers
Within the female carrier group (n = 93 due to no response from one participant), participants
self-identified most closely with the following personality attributes: ‘optimistic and social’
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(30/93, 32%), ‘short-tempered and irritable’ (29/93, 31%), ‘analytical and quiet’ (31/93, 33.5%)
and ‘relaxed and peaceful’ (3/93, 3.5%). Comparing these frequencies to large-scale worldwide
gender-specific data from a commercial company assessing personality traits within the gen-
eral population across >2million online tests (>1million individuals) [31] indicates that
within our sample there is a substantially elevated proportion of individuals self-identifying as
‘short-tempered or irritable’ (31% vs. 17.5%), and a lower proportion self-identifying as ‘ana-
lytical and quiet’ (33.5% vs. 43.5%) and ‘relaxed and peaceful’ (3.5% vs. 7%); the proportion of
individuals self-identifying as ‘optimistic and social’ was equivalent within our female carrier
sample and the general population sample (32% vs. 32%).
Previous developmental, psychiatric or neurodegenerative diagnoses in the
non-postpartum period in female carriers
A high proportion (39.5%) of our sample reported a previous non-postpartum diagnosis of a
developmental, psychiatric or neurodegenerative condition; 29.8% reported a previous mood
disorder diagnosis, 7.6% reported a previous developmental condition diagnosis, and 2.1%
reported a previous mixed mood and developmental condition diagnosis (Table 2).
Table 1. Demographic features of our sample of female carriers of genetic mutations associated with X-linked
ichthyosis (XLI).
Demographic feature Female carriers for XLI-
associated mutations (n = 94)
Age (yrs) 38.5 (95%CI: 36–41)
Country of residence United Kingdom 36 (38%)
United States of America 27 (29%)
Europe (excluding UK) 12 (13%)
Canada 7 (7%)
Rest of world 12 (13%)
Handedness Right-handed 83 (88%)
Left or mixed-handed 11 (12%)
Ethnicity White European or Hispanic 84 (89%)
African or Afro-Caribbean 4 (4%)
Asian 3 (3.5%)
Other or no response 3 (3.5%)
Highest level of education No formal education 1 (1%)
High school 23 (24.5%)
College or University 53 (56.5%)
Postgraduate 17 (18%)
History of regular smoking Yes 30 (32%)
No 64 (68%)
Basis of XLI carrier status Family history (i.e. multiple affected male
relatives) and skin appearance alone
59 (63%)
Family history, skin appearance and genetic/
hormonal test
35 (37%)
Test result for individuals
undergoing genetic analysis
Typical deletion or mutation within STS 15 (43%)
Atypical (large) deletion 3 (8.5%)
Don’t know or no response 17 (48.5%)
https://doi.org/10.1371/journal.pone.0212330.t001
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Adult ADHD Self-Report Scale (ASRS) scores in female carriers
A remarkably high proportion of carrier females (45/94, 48%) met the criteria for further
investigations for possible ADHD i.e.�4 symptoms in Part A of the screening questionnaire.
When compared to a mixed-gender adult (31.1±10.3yrs) general population sample from Swe-
den (n = 202, with no significant difference in scores between males and females)[32], our
female carrier sample scored significantly, and substantially, more highly on both the Part A
screener questions (12.2±4.8 vs. 8.9±3.5, t[141] = 5.96, p<0.0001) and on the total score mea-
sure (35.3±13.5 vs. 24.6±8.7, t[129] = 7.07, p<0.0001)(Cohen’s d = 0.79 and 0.94 respectively).
Within the female carrier sample, the total inattentive symptom count was significantly higher
than the total hyperactive-impulsive symptom count, and the total inattention scores were sig-
nificantly higher than total hyperactive-impulsive scores (both p<0.001)(Table 3). The three
carriers of large atypical deletions demonstrated marginally elevated numbers of total symp-
toms (8.7±5.7) but similar total scores (36.7±11.6) to the overall sample. The total ASRS symp-
toms and scores across the four individuals previously diagnosed with ADHD alone, or with
ADHD and comorbid depression, were 14.5±4.0 and 54.5±12.1 respectively, consistent with
the questionnaire being sensitive to ADHD-relevant behaviours.
Table 2. Developmental and mood disorders self-reported in our sample of female carriers of genetic mutations associated with X-linked ichthyosis (XLI).
Female carriers for XLI-associated
mutations (n = 94)
Previous diagnosis of a (non-postpartum) developmental, psychiatric or neurodegenerative condition 37 (39.5%)
Mood disorder Anxiety disorder alone 2 (2.1%)
Depression alone, or with comorbid anxiety, Obessive-Compulsive Disorder (OCD)
or Post-traumatic Stress Disorder (PTSD)
25 (26.5%)
Bipolar disorder alone, or with comorbid OCD 1 (1.1%)
Developmental conditions Attention Deficit Hyperactivity Disorder (ADHD)/Attention Deficit Disorder
(ADD) alone
3 (3.3%)
Autism spectrum condition 1 (1.1%)
Dyslexia alone 3 (3.2%)
Learning disability alone 1 (1.1%)
Mixed mood and developmental
conditions
Depression with comorbid ADHD 1 (1.1%)
https://doi.org/10.1371/journal.pone.0212330.t002
Table 3. Adult ADHD Self-Report Scale (ASRS) symptoms and scores in our sample of female carriers of genetic mutations associated with X-linked ichthyosis
(XLI).
Female carriers for XLI-associated mutations
(n = 94)
Normative adult mixed-gender sample (n = 202,
[32])
Statistical
comparison
Individuals with�4 symptoms in
Part A
45 (48%) - -
Total symptoms 7.5 (95%CI: 6–9) - -
Inattentive symptoms 5.0 (95%CI: 3.5–6) - -
Hyperactive-impulsive symptoms 3.0 (95%CI: 2–3) - -
Total score (0–4 for all 18 items) 35.3±13.5 24.6±8.7 t[129] = 7.07,
p<0.0001
Score (0–4 for 6 Part A items) 12.2±4.8 8.9±3.5 t[141] = 5.96,
p<0.0001
Score (0–4 for 12 Part B items) 23.1±94 - -
Score (inattention items) 19.4±7.4 - -
Score (hyperactive-impulsive items) 15 (95%CI: 13–17) - -
https://doi.org/10.1371/journal.pone.0212330.t003
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Barratt Impulsiveness Scale-11 (BIS-11) scores in female carriers compared
to female controls
All BIS-11 measures from our female carrier group (n = 92) were compared to a normative
sample of 1184 adult female college student and community-recruited participants screened
for Axis I psychiatric disorders and positive drug, alcohol or pregnancy tests (mean age
~21.5yrs) designed to be broadly reflective of the healthy general population of the USA [33];
total BIS-11 scores within our sample were also compared to an adult female general popula-
tion sample (n = 1503, mean age ~41.5yrs) from Canada screened for severe cognitive impair-
ments [34]. The mean total score for our female carrier sample (65.8±12.4) was towards the
high end of the usual range of impulsiveness (52–71) and was significantly, and substantially,
higher than that of both the USA (62.1±10.6) and Canadian (55.9±9.6) general population
samples (t[101] = 2.77, p<0.01, and t[97] = 7.50, p<0.0001, Cohen’s d = 0.32 and 0.89 respec-
tively). Individuals carrying atypical large deletions performed similarly to the overall carrier
sample on the total BIS-11 score measure (66.7±7.6). The total BIS-11 score across the four
individuals previously diagnosed with ADHD alone, or ADHD with comorbid depression,
was extremely high (85.0±8.5) consistent with the questionnaire being sensitive to clinically-
relevant impulsive traits. In terms of second order BIS-11 factors, carrier females scored more
highly than USA general population controls on attentional and non-planning impulsivity,
but did not differ in terms of motor impulsivity; with respect to first order factors, female carri-
ers scored more highly than general population controls on measures of attention, cognitive
instability, perseverance, and self-control, but equivalently on a measure of cognitive complex-
ity, and lower (though not significantly so) on a specific measure of motor impulsivity
(Table 4).
Autism Quotient (AQ) scores in female carriers compared to female
controls
All AQ measures from our female carrier group (n = 90) were compared to a normative sam-
ple of 98 unscreened adult female participants recruited from the UK general population
(mean age ~37yrs)[25]; total AQ scores from our sample were also compared to a large adult
female general population sample recruited online and screened for autism and other psychiat-
ric disorders (n = 2562, aged 34.4±4.4yrs) [35]. The total score for our female carrier sample
(21.0 (95%CI: 18.0–23.0); 21.6±8.8) was towards the high end of the usual female range for
autism-related traits [25], and was significantly, and substantially, higher than that of both the
Table 4. Barratt Impulsiveness Scale-11 (BIS-11) scores in our sample of female carriers of genetic mutations associated with X-linked ichthyosis (XLI) and a nor-
mative general population control sample.
Female carriers for XLI-associated mutations (n = 92) Normative adult female sample (n = 1184, [33]) Statistical comparison
Total score 65.8±12.4 62.1±10.6 t[101] = 2.77, p = 0.0067
Attentional impulsivity 18.0±4.9 16.7±4.1 t[101] = 2.53, p = 0.01
Motor impulsivity 22.0 (95%CI: 20.0–23.5); 22.5±4.9 21.8±4.1 t[101] = 1.38, p = 0.17
Non-planning impulsivity 25.2±5.2 23.6±5.0 t[104] = 2.91, p<0.005
Attention 11.0 (95%CI: 10.0–12.0); 11.1±3.3 10.4±2.9 t[102] = 2.02, p = 0.05
Cognitive instability 7.0 (95%CI: 6.0–8.0); 6.9±2.2 6.3±1.9 t[101] = 2.54, p = 0.01
Motor 14.0 (95%CI: 13.0–15.5); 14.8±4.0 15.0±3.4 t[101] = -0.56, p = 0.57
Perseverance 8.0 (95%CI: 7.0–8.0); 7.8±2.0 6.8±1.7 t[101] = 4.58, p<0.001
Self-control 13.4±3.6 12.0±3.3 t[103] = 3.53, p<0.001
Cognitive complexity 11.9±2.6 11.6±2.6 t[105] = 0.96, p = 0.34
https://doi.org/10.1371/journal.pone.0212330.t004
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smaller (15.4±5.7) and larger (17.1±7.6) normative general population samples (t[150] = 5.66,
p<0.0001 and t[93] = 4.77, p<0.0001, Cohen’s d = 0.84 and 0.55 respectively). The three indi-
viduals carrying atypical large deletions scored more highly, on average, than the overall car-
rier sample on the total AQ score measure (30.0±11.5). The female carrier previously
diagnosed with autism had a total score of 34 on the AQ, consistent with the questionnaire’s
senstivity to autism-related traits. On four out of five AQ subscales, the female carrier sample
scored significantly more highly than the normative control sample; however, on the ‘Atten-
tion to Detail’ subscale, there was no significant difference between the two groups’ scores
(Table 5).
Kessler Psychological Distress Scale (K10) scores in female carriers
compared to female controls
Data from the female carrier sample (n = 91) were compared to normative data from an
unscreened community-recruited Australian adult female sample comprising 882 individuals
(35–44yrs) [36]. Total scores in the female carrier sample were significantly, and substantially,
larger than those seen in the normative sample (23.0 (95%CI: 20.0–25.0); 23.6±8.5 vs. 15.5±8.9
respectively, t[111] = 8.63, p<0.0001), Cohen’s d = 0.93) and were in the range consistent with
the presence of a mild mental disorder (20–24). Compared to the overall female carrier sample,
the three female carriers of atypical deletions exhibited slightly lower than average total K10
scores (21.7±5.7). As expected, the 25 individuals with a previous diagnosis of depression
alone, or depression with another comorbid psychiatric condition, had high K10 scores (29.9
±8.5), consistent with a diagnosis of a moderate-severe mental disorder.
Schizotypal Personality Questionnaire (SPQ) scores in female carriers
compared to female controls
SPQ data from the female carrier sample (n = 88) were compared to normative data from an
unscreened sample of adult (39.8±10.3yrs) females (n = 184) recruited from the community in
Australia [37]. Female carriers exhibited significantly, and substantially, higher total SPQ
scores than the normative sample (24.0 (95%CI: 20.0–28.5);25.5±15.2 vs.15.9±11.4 respec-
tively, t[134] = 5.43, p<0.0001, Cohen’s d = 0.73). The total SPQ scores for the two female car-
riers with atypical deletions who completed this questionnaire were on the lower side of the
average for the carrier group (16.5±6.4). On the majority of SPQ subscales, carrier females
scored significantly more highly than females from the normative sample; however, on the
‘Unusual Perceptual Experiences’ measure the two groups performed equivalently, whilst the
female carrier group scored nominally-significantly lower on the ‘Odd beliefs and magical
thinking’ measures (Table 6).
Table 5. Autism Quotient (AQ) scores in our sample of female carriers of genetic mutations associated with X-linked ichthyosis (XLI) and a normative general pop-
ulation control sample.
Female carriers for XLI-associated mutations (n = 90) Normative adult female sample (n = 98, [25]) Statistical comparison
Total score 21.0 (95%CI: 18.0–23.0); 21.6±8.8 15.4±5.7 t[150] = 5.66, p<0.0001
Social skill 4.0 (95%CI: 2.0–5.0); 4.0±2.9 2.3±2.2 t[164] = 4.51, p<0.0001
Attention switching 5.0 (95%CI: 4.5–6.0); 5.3±2.4 3.6±1.8 t[166] = 5.67, p<0.0001
Attention to detail 5.0 (95%CI: 4.0–6.0); 5.3±2.4 5.4±2.3 t[183] = -0.36, p = 0.72
Communication 3.0 (95%CI: 3.0–4.0); 3.9±2.4 2.1±1.8 t[164] = 5.70, p<0.0001
Imagination 2.0 (95%CI: 2.0–3.0); 3.1±2.2 1.9±1.5 t[153] = 4.16, p<0.0001
https://doi.org/10.1371/journal.pone.0212330.t005
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Relationship between psychological questionnaire scores in female carrier
sample
Within the female carrier sample, all total questionnaire scores (ASRS, BIS-11, AQ, K10 and
SPQ) were highly significantly correlated with one another (correlation coefficients>0.48,
p<0.001) apart from BIS-11 and AQ total scores which were moderately significantly corre-
lated (Spearman’s rho = 0.22, p = 0.04).
Comparison of demographics and psychological questionnaire scores in
female carrier sample and previous sample of adult males with XLI
We compared the demographics and total ASRS, BIS-11, AQ and K10 scores from our female
carrier sample to a previously-ascertained adult male sample with XLI [9](Table 7). The two
samples were well-matched for most demographic variables, although our female carrier sam-
ple was significantly more highly-educated. On average, total questionnaire scores were consis-
tently lower in the female carrier than in the male XLI group, but they were only significantly
lower in the case of the AQ and K10 measures (and only nominally so for the AQ) (Table 7).
Comparison of demographics of female carrier mothers and general
population sample of UK and US mothers
83 of our female carrier sample had given birth to at least one child, and we recruited 263
mothers from the general UK and USA populations as a control sample. The control sample,
on average, were marginally younger at survey completion than the female carrier sample, had
their first child at a slightly younger age, and had slightly fewer children overall; the two sam-
ples did not differ significantly on any other demographic measure we assessed (Table 8).
Pregnancy and postpartum-related medical complications and mental
health conditions in female carriers compared to general population
mothers
As expected, female carriers of mutations associated with XLI exhibited a significantly, and
substantially (>threefold), higher rate of delayed or prolonged labour relative to females from
the general population; the two groups did not differ with respect to any of the other preg-
nancy or childbirth-related medical conditions we examined (Table 9).
Table 6. Schizotypal Personality Questionnaire (SPQ) scores in our sample of female carriers of genetic mutations associated with X-linked ichthyosis (XLI) and a
normative general population control sample.
Female carriers for XLI-associated mutations (n = 88) Normative adult female sample (n = 184, [37]) Statistical comparison
Total score 24.0 (95%CI: 20.0–28.5); 25.5±15.2 15.9±11.4 t[135] = 5.27, p<0.0001
Ideas of reference 2.4±2.5 1.71±2.06 t[146] = 2.33, p = 0.02
Excessive social anxiety 4.0 (95%CI: 3.0–6.0); 4.4±2.8 3.04±2.39 t[150] = 3.88, p<0.0005
Odd beliefs or magical
thinking
1.0 (95%CI: 0.0–1.0); 1.5±1.7 2.08±1.81 t[179] = -2.76,
p = 0.0064
Unusual perceptual
experiences
2.0 (95%CI: 1.0–2.0); 2.1±2.0 1.91±2.10 t[182] = 0.65, p = 0.52
Odd or eccentric behaviour 1.0 (95%CI: 0.5–2.0); 2.0±2.1 0.75±1.43 t[126] = 5.05, p<0.0001
No close friends 3.0 (95%CI: 2.0–5.5); 3.9±3.0 1.49±1.84 t[120] = 6.93, p<0.0001
Odd speech 4.0 (95%CI: 3.0–5.0); 3.8±2.6 2.40±2.13 t[144] = 4.32, p<0.0001
Constricted affect 2.0 (95%CI: 2.0–3.0); 2.7±2.3 1.05±1.28 t[114] = 6.37, p<0.0001
Suspiciousness 2.0 (95%CI: 2.0–3.0); 2.9±2.5 1.51±1.80 t[132] = 4.56, p<0.0001
https://doi.org/10.1371/journal.pone.0212330.t006
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Female carriers exhibited a significantly elevated (~1.5fold) burden of all aggregated post-
partum mental health conditions, and ‘depressive’ postpartum mental health conditions, rela-
tive to general population controls (Table 10). Importantly, this finding was unlikely to be due
to the former group being exposed to more adverse external social circumstances during preg-
nancy and postnatally; in fact there was a trend for the opposite to be the case (Table 10). For
specific postpartum conditions, only the prevalence of ‘baby blues’ (mild depression not
requiring further medical treatment) was significantly higher in the female carrier group
(Table 10). Both females carrying large atypical deletions reported experiencing the ‘baby
blues’ following one or more pregnancies. We tested whether there was any relationship
Table 7. Demographics and total psychological questionnaire scores in our sample of female carriers of genetic mutations associated with X-linked ichthyosis (XLI)
and adult males with XLI.
Female carriers for XLI-associated
mutations (n = 91–94)
Males with XLI
(n = 44–58, [9])
Statistical
comparison
Demographic measure Age (yrs) 38.5 (95%CI: 36–41) 39.5 (95%CI: 33–47) U = 2716.5,
p = 0.97
Country of residence
(UK/USA/Other)
36 (38%)/27(29%)/31(33%) 23(40%)/19(32%)/16
(28%)
χ2[2] = 0.55,
p = 0.76
Handedness
(Right/Left or Mixed)
83(88%)/11(12%) 49(84%)/9(16%) χ2[1] = 0.18,
p = 0.67
Ethnicity
(White European or Hispanic/Other)
84(89%)/10(11%) 46(79%)/12(21%) χ2[1] = 2.17,
p = 0.14
Highest level of education
(No formal or high school/college or
University/postgraduate)
24(26%)/53(56%)/17(18%) 24(41%)/32(55%)/2
(4%)
χ2[2] = 9.01,
p = 0.01
Psychological questionnaire
measure
Total ASRS score 35.3±13.5 36.7±11.6 t[141] = -0.60,
p = 0.55
Total BIS-11 score 65.8±12.4 68.8±14.1 t[137] = -1.32,
p = 0.19
Total AQ score 21.0 (95%CI: 18.0–23.0); 21.6±8.8 23.9±5.9 U = 1604.5,
p = 0.05
Total K10 score 23.0 (95%CI: 20.0–25.0); 23.6±8.5 28.4±9.5 U = 1393.0,
p<0.005
https://doi.org/10.1371/journal.pone.0212330.t007
Table 8. Demographics of our sample of female carriers of genetic mutations associated with X-linked ichthyosis (XLI) and our adult female general population
sample of mothers.
Demographic variable Female carrier mothers for XLI-associated
mutations (n = 83)
General UK and USA population sample of
mothers (n = 263)
Statistical
comparison
Age (yrs) 39.0 (95%CI: 37.0–42.0) 37.0 (95%CI: 35.0–38.0) U = 8287.5,
p = 0.001
Age at first child (yrs) 27.4±5.4 25.0 (95%CI: 24.0–26.0); 25.5±5.7 U = 6650.5,
p = 0.005
Number of children 2.0 (95%CI: 2.0–2.0) 2.0 (95%CI: 2.0–2.0) U = 9138.0,
p = 0.04
Handedness
(Right/Left or Mixed)
75(90%)/8(10%) 233(89%)/30(11%) χ2[1] = 0.06,
p = 0.81
Ethnicity
(White European or Hispanic/Other)
75(90%)/8(10%) 237(90%)/26(10%) χ2[1] = 0.02,
p = 0.89
Highest level of education
(No formal or high school/college or
University/postgraduate)
22(27%)/45(54%)/16(19%) 75(29%)/154(59%)/33(12%)
(1 no response)
χ2[2] = 2.31,
p = 0.32
Smoking status
(Regular smoker/Non-smoker)
30(36%)/53(63%) 123(47%)/140(53%) χ2[1] = 2.47,
p = 0.12
https://doi.org/10.1371/journal.pone.0212330.t008
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between stressful childbirth i.e. delayed or prolonged labour and an increased rate of postpar-
tum mental health conditions in our carrier sample: 26 female carriers experienced both
delayed/prolonged labour and a postpartum mental health condition, 26 delayed/prolonged
labour but no postpartum mental health condition, 12 no delayed/prolonged labour but a post-
partum mental health condition, and 19 no delayed/prolonged labour and no postpartum
mental health condition (χ2[1] = 0.59, p = 0.44). We also tested the postpartum-specificity of
our findings by assessing whether carrier females who reported a postpartum mental health
condition (n = 38) scored more highly than those who didn’t (n = 45) on the K10 ‘baseline’
(non-postpartum) measure of depressive and anxiety-related traits; whilst the former group
scored more highly, on average, on the K10 (25.5±9.0 vs. 22 (95%CI: 19.0–24.0); 22.4±8.0), this
was not significant (U = 672.5, p = 0.10). Female carriers who reported a postpartum mental
health condition were not currently older, did not have their first child later, and did not have
more children, than female carriers who did not report a postpartum mental health condition;
Table 9. Pregnancy and childbirth-related medical complications in our sample of female carriers of genetic mutations associated with X-linked ichthyosis (XLI)
and our adult female general population sample of mothers; note that one individual could have experienced multiple complications.
Female carrier mothers for XLI-
associated mutations (n = 83)
General UK and USA population
sample of mothers (n = 263)
Statistical
comparison
Medical complications during
pregnancy or childbirth
Delayed or prolonged
labour
52(63%) 50(19%) χ2[1] = 55.7,
p<0.0001
Premature labour 17(20%) 53(20%) χ2[1] = 0.01,
p = 0.92
Loss of pregnancy or
miscarriage
17(20%) 63(24%) χ2[1] = 0.25,
p = 0.62
Pre-eclampsia or high
blood pressure
14(17%) 40(15%) χ2[1] = 0.04,
p = 0.84
Gestational diabetes 12(14%) 20(8%) χ2[1] = 2.76,
p = 0.10
Thyroid problems 5(6%) 14(5%) χ2[1] = 0.0,
p = 1.00
https://doi.org/10.1371/journal.pone.0212330.t009
Table 10. Postpartum mental health conditions in our sample of female carriers of genetic mutations associated with X-linked ichthyosis (XLI) and our adult
female general population sample of mothers; note that one individual could have experienced multiple conditions.
Female carrier mothers for XLI-
associated mutations (n = 83)
General UK and USA population
sample of mothers (n = 263)
Statistical
comparison
Presence of any postpartum mental health condition 38(46%) 83(32%) χ2[1] = 5.00,
p = 0.03
Postpartum depressive condition (‘baby blues’ or
postpartum depression)
34(41%) 70(27%) χ2[1] = 5.51,
p = 0.02
Obvious external social factors contributing to
postpartum mental health condition (Yes/No)
15(39%)/17(45%)
(6 no response (16%))
52(63%)/30(36%)
(1 no response (1%))
χ2[1] = 1.96,
p = 0.16
‘Baby blues’ or mild depression not requiring further
medical treatment
23(28%) 39(15%) χ2[1] = 6.27,
p = 0.01
Postpartum depression requiring further medical
treatment
16(19%) 38(14%) χ2[1] = 0.78,
p = 0.38
Postpartum psychosis 1(1%) 3(1%) p = 1.00
Postpartum anxiety 6(7%) 19(7%) χ2[1] = 0.06,
p = 0.81
Postpartum post-traumatic stress disorder (PTSD) 6(7%) 10(4%) p = 0.23
Postpartum obsessive-compulsive disorder (OCD) 2(2%) 6(2%) p = 1.00
Postpartum-onset bipolar disorder 0(0%) 6(2%) p = 0.34
https://doi.org/10.1371/journal.pone.0212330.t010
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age: 41.7±9.4yrs vs. 41.0 (95%CI: 35.0–46.0); 42.6±11.8yrs (U = 838.0, p = 0.88), age at first
child: 27.9±5.0yrs vs. 26.9±5.7yrs (t[70] = 0.77, p = 0.44), and number of children: 2.0 (95%CI:
2.0–2.0) vs. 2.0 (95%CI: 2.0–2.0)(U = 855.0, p = 1.00) respectively.
Community Assessment of Psychic Experiences (CAPE-42) scores related
to the postpartum period in female carrier and general population mothers
We attempted to obtain a quantitative measure of positive, depressive and negative experiences
related to psychosis in the postpartum period using the CAPE-42 [28] in our female carrier
and general population samples. Female carriers reported significantly less frequent positive
dimension psychosis-related experiences than females from the general population, but these
experiences, when they occurred, caused equivalent amounts of distress in both groups
(Table 11). Whilst the average frequency of depressive psychosis-related experiences (and the
distress caused by these) was greater in the female carrier group, the two groups did not differ
significantly; nor was there any significant group diffference with respect to the frequency of,
or distress caused by, negative dimension psychosis-related experiences (Table 11). The two
females carrying large atypical deletions scored similarly to the overall carrier sample (�2 on
all measures). Within the female carrier group, those reporting postpartum mental health con-
ditions (n = 37) scored significantly higher on depressive (frequency and distress) and negative
(frequency and distress) dimension experiences compared to those not reporting such condi-
tions (n = 44): 2.45±0.69 vs. 2.09±0.63 (t[77] = 3.43, p = 0.001), 2.63±0.72 vs. 2.25±0.62 (t[77]
= 3.54, p = 0.001), 2.14 (95%CI:1.79–2.57) vs. 1.79 (95%CI:1.57–2.14) (U = 504.5, p = 0.003),
and 2.09±0.57 vs. 1.87±0.42 (t[77] = 2.34, p = 0.02) respectively; these two groups did not differ
with respect to positive dimension experience frequency (1.20 (95%CI:1.10–1.25) vs. 1.25
(95%CI:1.20–1.30)(U = 721.5, p = 0.38)) or associated distress (2.00 (95%CI:1.77–2.11 vs. 1.60
(95%CI:1.25–2.00)(U = 366.5, p = 0.11)). Hence, the CAPE-42, as applied to the postpartum
period, does appear to be sensitive to mental health symptoms.
Discussion
The pattern of non-postpartum psychiatric and behavioural traits demonstrated across multi-
ple converging measures in our well-powered sample of carrier females bears remarkable simi-
larities to that exhibited by adult males affected by XLI [9] i.e. a moderately increased
prevalence of developmental/mood diagnoses (4.3% ADHD vs. ~2.5% in general adult female
population [38], 1.1% autism vs. ~0.1% in general adult female population [39] and 27.6%
depression vs. ~26.7% lifetime prevalence in adult female USA general population aged 35-
Table 11. Community Assessment of Psychic Experiences-42 (CAPE-42) scores in our sample of female carriers of genetic mutations associated with X-linked
ichthyosis (XLI) and our adult female general population sample of mothers.
Female carrier mothers for XLI-associated
mutations (n = 81)
General UK and USA population sample of mothers
(n = 263)
Statistical
comparison
Positive dimension
(frequency)
1.25 (95%CI:1.18–1.30) 1.28 (95%CI:1.25–1.35) U = 8088.5, p = 0.001
Positive dimension (distress) 2.00 (95%CI:1.61–2.00) 2.00 (95%CI: 2.00–2.00) U = 6159.5, p = 0.11
Depressive dimension
(frequency)
2.25 (95%CI:2.00–2.38) 2.13 (95%CI:2.06–2.25) U = 10488.0, p = 0.83
Depressive dimension
(distress)
2.47±0.68 2.31 (95%CI:2.17–2.40); 2.35±0.77 U = 9643.0, p = 0.55
Negative dimension
(frequency)
2.00 (95%CI:1.71–2.14) 1.96 (95%CI:1.86–2.07) U = 10422.5, p = 0.77
Negative dimension (distress) 2.00±0.50 2.00 (95%CI:1.97–2.10); 2.02±0.68 U = 8780.0, p = 0.13
https://doi.org/10.1371/journal.pone.0212330.t011
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49yrs [40]), together with generally elevated inattentive, irritable, impulsive, and depression,
autism and anxiety-related traits relative to gender-matched control subjects, but with equiva-
lent, or reduced, levels of motor impulsivity and ‘attention to detail’. The relatively high rate of
developmental conditions within our female carrier sample is in line with data from the DECI-
PHER database [41] in which related phenotypes (e.g. developmental delay, language impair-
ments, intellectual disability, autism and inattention) are frequently seen in female carriers
with comparatively small genetic deletions (<2Mb) encompassing STS (S4 Table). The consis-
tency of findings across female carriers and males with XLI (and, additionally, with rodent
model work), indicates that our previously-reported observations regarding the neurobeha-
vioural features associated with STS deficiency are robust and generalisable. Here, we further
showed that female carriers generally exhibit higher levels of schizotypal personality-related
traits than age and gender-matched controls, although with respect to ‘positive’ psychotic
experience-related measures the former group scored lower or equivalently; schizotypal per-
sonality-related traits were not assayed in males with XLI. The observation that individuals
carrying atypical deletions were largely similar to individuals carrying smaller mutations, apart
from on the AQ where they scored slightly higher, is consistent with the idea that a gene absent
in atypical but not atypical deletions (most likely NLGN4X) is relatively specifically involved in
autism-related behavioural phenotypes [2]. Our observation that multiple questionnaire scores
were strongly correlated with one another suggests one or more possibilities regarding the
effects of STS deficiency: a) it has pleiotropic effects across multiple brain regions/psychologi-
cal processes, the magnitude of which can vary between individuals, b) it impacts predomi-
nantly upon one core cognitive/psychological process common to multiple behavioural
phenotypes e.g. attention, or c) it impacts upon one or more psychological processes in early
development and subsequent adult behaviours are a response to the effects of this e.g. early
high levels of autism-related traits may feasibly result in a later expression of depression and
anxiety-related traits through a variety of mechanisms, including increased victimisation [42].
Future work involving detailed longitudinal characterisation of neuropsychological differences
in carrier females and males with XLI should help to resolve which of these mechanisms is
most plausible. It is also important to recognise that psychological traits in female carriers may
conceivably be affected by both biological factors (STS deficiency and its physiological conse-
quences) and environmental/social factors e.g. the stress of raising a child, or children, with a
long-term medical condition (XLI).
In males with XLI, the STS enzyme is generally completely absent, whereas in carrier
females it is expected to be haploinsufficient; hence, after allowing for normal gender differ-
ences in the expression of some psychological traits, we expected carrier females to demon-
strate milder phenotypes. Whilst autism and depression/anxiety-related traits were
significantly lower in carrier females than males with XLI, the two groups did not differ signifi-
cantly with respect to ADHD-related traits or impulsivity (although average values were
slightly lower in carrier females); these latter findings suggest that any true difference between
carrier females and males with XLI (who are known to be at significantly elevated risk of
ADHD) on ADHD-relevant measures is likely to be relatively small.
With respect to medical conditions associated with pregnancy and childbirth, we specifi-
cally observed the expected, and marked, elevation in prolonged/delayed labour in female car-
riers relative to females from the general population; this ‘control’ result provides
confirmatory evidence that self-identified ‘carriers’ for XLI-associated genetic mutations are
likely to be true carriers, and suggests that participants provided largely-accurate retrospective
medical histories.
We successfully managed to recruit and phenotype a closely demographically-matched gen-
eral population sample of mothers to compare with our female carrier sample. Importantly,
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self- and retrospectively-reported rates of postpartum psychiatric diagnoses in this normative
sample were highly-consistent with previous epidemiological evidence from females within
the general population [43] i.e. 14% vs. ~13% for postpartum depression, and 7% vs. ~10% for
postpartum anxiety. Consistent with one of our original hypotheses, we identified a signifi-
cantly, and substantially (~1.5-fold), higher burden of aggregated postpartum psychiatric con-
ditions in our female carrier sample relative to the control sample; this group difference was
primarily driven by a higher prevalence of depressive conditions (particularly in the mild cate-
gory) and could not be readily explained by differential adverse social circumstances between
the groups. We previously proposed that STS deficiency may predispose to postpartum psy-
chosis [20]. Here, we found no evidence that carrier status confers very large increases in post-
partum psychosis risk, but given both the low prevalence and the likely complex and polygenic
nature of this condition, and our limited sample size, the possibility that STS deficiency mod-
erately increases risk cannot be completely discounted. However, using the CAPE-42 measure
applied to the postpartum period, we found no evidence for an increased rate of psychosis-
related experiences across the female carrier group relative to the normative sample; indeed,
consistent with the SPQ finding, the frequency of positive dimension experiences was actually
lower in the carrier group.
The increased rate of depressive postpartum disorders in our female carrier sample could
potentially have been due to the fact that this group was slightly older than the normative sam-
ple, had their children later (increased maternal age is a risk factor for postpartum mood con-
ditions [44]), and had more children (hence, more opportunity for developing postpartum
mental health problems); however, the size of the between-group differences on these demo-
graphic variables was small, and we found no evidence that female carriers reporting, or not
reporting, postpartum mental health conditions differed with respect to any of these demo-
graphic measures. Our data suggest no clear relationship between delayed/prolonged labour
and later postpartum psychiatric distress in female carriers, although given the relatively low
power of our sample for this analysis a subtle relationship between these variables cannot be
definitively ruled out; this would be interesting to explore further given comparatively high
rates of caesarian births in female carriers (due to prolonged labour) and a putative relation-
ship between caesarian birth and postpartum stress [45]. As female carriers with postpartum
psychiatric diagnoses did not differ significantly from those with no postpartum psychiatric
diagnosis on the K10 measure of recent depression and anxiety-related traits, we tentatively
speculate that STS deficiency in late pregnancy and the postpartum period may exacerbate any
non-postpartum psychiatric symptoms at these timepoints.
Our study has a number of limitations, notably: a) a lack of objective clinical and genetic
confirmation, b) the possibility of response bias whereby more severely affected individuals are
more motivated to participate in the study, and c) a reliance upon previously-published norma-
tive data and self, and retrospectively-reported, data. Additionally, as referred to above, the find-
ings are simply descriptive and cannot shed light upon the mechanistic processes via which STS
deficiency might ultimately impact upon physiology. We argue that these limitations do not sig-
nificantly impact upon our main conclusions for the following reasons: a) participants were
only included in the analyses if their carrier status was highly likely, and, consistent with this,
our carrier sample exhibited expected physiological and behavioural features (i.e. high rates of
delayed/prolonged labour and significant phenotypic overlap with males with XLI), b) there is
no strong a priori reason to suspect response bias in that female carrier status has traditionally
been considered to have little, or no, effect on phenotype, and c) carriers were explicitly com-
pared to large control cohorts representative of the general population which were demographi-
cally very well (but not perfectly) matched, and for which data had been obtained in the same
manner (i.e. by retrospective self-report on exactly the same measures).
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Conclusions
The current data, together with previous work, help to confirm a psychological and psychiatric
profile for individuals with STS deficiency; future basic science in males with XLI, in female
carriers, and in rodent models will aim to identify and characterise the biological (neural and
endocrine) substrates which mediate the behavioural and psychiatric phenotypes described
above; these analyses could provide clinically-relevant information on possible new therapeu-
tic targets, and insights of more general relevance to the pathophysiology of idiopathic devel-
opmental and mood disorders. Previous work assaying STS gene expression in developing
human brain, and on the neurochemical and genetic sequelae of STS loss of function in
rodents, has provided initial clues as to neural substrates requiring more focussed investiga-
tion: specifically, these studies have implicated corticostriatothalamic, hippocampal, and cere-
bellar (dys)function, changes in the cholinergic and serotonergic systems, and a suite of gene
expression changes [7,13,14,19,46,47]. We have previously argued that acute inhibition of STS
in the postpartum period in mice may elicit effects on maternal behaviour via increased brain
expression of CCN protein family members [48]; the recent finding that CTGF (also known as
CCN2) is a prodepressant [49] suggests that elevated expression of this protein could partially
explain the excess of postpartum depressive phenotypes in our carrier female sample.
We hope that the present information will help to continue to raise awareness of beha-
vioural/psychiatric features associated with XLI (and carrier status for associated genetic muta-
tions) amongst: a) families affected by the condition, b) relevant medical professionals
(General Practitioners, dermatologists, psychologists/psychiatrists and obstetricians), c)
patient support charities and groups, and d) genetic counsellors, such that affected individuals
have the best possible access to advice and multidisciplinary medical care should it be required.
Finally, the current findings, and planned future work, may be useful for understanding the
basis of neurobehavioural/cognitive abnormalities including elevated autism, ADHD and anx-
iety risk in females with Turner syndrome (X-monosomy) in which STS expression is haploin-
sufficient [50–52].
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